Karpas Strategies’s CVS Health CVS Stock Holding History

Karpas Strategies’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$869K	Buy	14,714 +83	+0.6%	+$5.19K	0.27%	67
2024 Q1	$1.17M	Buy	14,631 +61	+0.4%	+$4.66K	0.36%	56
2023 Q4	$1.15M	Sell	14,570 -989	-6%	-$70.4K	0.38%	57
2023 Q3	$1.09M	Sell	15,559 -286	-2%	-$20.3K	0.4%	51
2023 Q2	$1.1M	Buy	15,845 +66	+0.4%	+$4.7K	0.37%	56
2023 Q1	$1.17M	Sell	15,779 -245	-2%	-$20.5K	0.41%	51
2022 Q4	$1.49M	Buy	16,024 +43	+0.3%	+$4.15K	0.52%	48
2022 Q3	$1.52M	Sell	15,981 -253	-2%	-$25K	0.58%	43
2022 Q2	$1.5M	Buy	16,234 +45	+0.3%	+$4.39K	0.53%	44
2022 Q1	$1.64M	Buy	16,189 +41	+0.3%	+$4.31K	0.52%	44
2021 Q4	$1.67M	Hold	16,148	–	–	0.53%	45
2021 Q3	$1.47M	Hold	16,148	–	–	0.49%	46
2021 Q2	$1.35M	Hold	16,148	–	–	0.48%	46
2021 Q1	$1.22M	Hold	16,148	–	–	0.46%	46
2020 Q4	$1.1M	Hold	16,148	–	–	0.43%	52
2020 Q3	$943K	Hold	16,148	–	–	0.43%	50
2020 Q2	$1.05M	Hold	16,148	–	–	0.5%	46
2020 Q1	$958K	Hold	16,148	–	–	0.52%	45
2019 Q4	$1.2M	Hold	16,148	–	–	0.45%	48
2019 Q3	$1.02M	Hold	16,148	–	–	0.41%	49
2019 Q2	$880K	Hold	16,148	–	–	0.37%	54
2019 Q1	$871K	Hold	16,148	–	–	0.37%	54
2018 Q4	$1.06M	Hold	16,148	–	–	0.49%	46
2018 Q3	$1.27M	Hold	16,148	–	–	0.53%	45
2018 Q2	$1.04M	Hold	16,148	–	–	0.45%	49
2018 Q1	$1M	Hold	16,148	–	–	0.44%	52
2017 Q4	$1.17M	Hold	16,148	–	–	0.5%	47
2017 Q3	$1.31M	Hold	16,148	–	–	0.58%	44
2017 Q2	$1.3M	Hold	16,148	–	–	0.59%	42
2017 Q1	$1.27M	Hold	16,148	–	–	0.58%	41
2016 Q4	$1.27M	Hold	16,148	–	–	0.6%	40
2016 Q3	$1.44M	Hold	16,148	–	–	0.7%	38
2016 Q2	$1.55M	Hold	16,148	–	–	0.77%	35
2016 Q1	$1.68M	Hold	16,148	–	–	0.87%	35
2015 Q4	$1.58M	Hold	16,148	–	–	0.83%	36
2015 Q3	$1.56M	Sell	16,148 -100	-0.6%	-$10.5K	0.86%	34
2015 Q2	$1.7M	Sell	16,248 -200	-1%	-$20.4K	0.85%	34
2015 Q1	$1.7M	Sell	16,448 -503	-3%	-$50.9K	0.82%	34
2014 Q4	$1.63M	Hold	16,951	–	–	0.78%	35
2014 Q3	$1.35M	Hold	16,951	–	–	0.67%	39
2014 Q2	$1.28M	Hold	16,951	–	–	0.64%	40
2014 Q1	$1.27M	Hold	16,951	–	–	0.67%	41
2013 Q4	$1.21M	Hold	16,951	–	–	0.67%	42
2013 Q3	$962K	Hold	16,951	–	–	0.56%	43
2013 Q2	$969K	Buy	+16,951	New	+$982K	0.59%	43

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Karpas Strategies's CVS Position: Q2 2024 in Review

Karpas Strategies increased its CVS Health (CVS) stake by 0.57% in Q2 2024, buying an estimated $5.19K and bringing the position to 14,714 shares worth $869K. The position accounts for 0.27% of the portfolio, ranked #67.

Karpas Strategies first reported a position in CVS in Q2 2013 and has held it in 45 quarters since. The position peaked at $1.7M in Q2 2015. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Karpas Strategies held 14,714 shares of CVS Health worth $869K as of Q2 2024.
Karpas Strategies bought 83 CVS Health shares in Q2 2024, an estimated $5.19K.
CVS Health made up 0.27% of Karpas Strategies's portfolio in Q2 2024, its #67 holding.
Karpas Strategies first reported a position in CVS Health in Q2 2013 and has held it in 45 quarters since.
Karpas Strategies's CVS Health position peaked at $1.7M in Q2 2015.
1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Karpas Strategies's 13F filing for Q2 2024, filed 30 Jul 2024.